Orexo AB´s sustainability work ranked among top 5% by EcoVadis

It showcases the outcome of dedicated sustainability activities undertaken over the last several years across social, environmental and governance areas of Orexo AB. And it shows how the employees and partners are working together to achieve successes across four areas: Environment, Labor and Human Rights, Ethics and Sustainable Procurement. It showcases the outcome of dedicated sustainability activities undertaken over the last several years across social, environmental and governance areas of Orexo AB...
Comunicato Precedente

next
Comunicato Successivo

next
Sweden, (informazione.it - comunicati stampa - salute e benessere)

It showcases the outcome of dedicated sustainability activities undertaken over the last several years across social, environmental and governance areas of Orexo AB. And it shows how the employees and partners are working together to achieve successes across four areas: Environment, Labor and Human Rights, Ethics and Sustainable Procurement.

Nikolaj Sørensen, President and CEO, of Orexo, said, "Achieving this rating is a privilege and we will continue setting ambitious goals in our active pursuit of an even more sustainable and inclusive future for everyone. This is central to our values-based approach to growth and underpins optimal outcomes for patients, investors, the company and society more broadly."

Contacts:
Nikolaj Sørensen, President and CEO
Lena Wange, IR & Communications Director
[email protected]
+46 (0)18 780 88 00

Related links
EcoVadis: https://ecovadis.com/
Sustainability at Orexo: https://orexo.com/sustainability/ 

About Orexo

Orexo is a Swedish pharmaceutical company with over 25 years of experience developing improved pharmaceuticals based on proprietary formulation technologies that meet large medical needs. On the US market, Orexo provides innovative treatment solutions for patients suffering from opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with leading partners. Total net sales in 2023 amounted to SEK 639 million, and the number of employees to 116. Orexo is listed on Nasdaq Stockholm's main list and is available as an ADR on OTCQX (ORXOY) in the US.

For more information about Orexo please visit www.orexo.com.  You can also follow Orexo on X, LinkedIn, and YouTube.

The information was submitted for publication at 8 a.m. CET, on July 10, 2024.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/orexo/r/orexo-ab-s-sustainability-work-ranked-among-top-5--by-ecovadis,c4013283

The following files are available for download:

 

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/orexo-abs-sustainability-work-ranked-among-top-5-by-ecovadis-302193098.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Slide ShowSlide Show
Non disponibili